Sean Fenske: What technology or service are you emphasizing at Medica/CompaMed this year?
Florence Joffroy-Black: MedWorld Advisors had the pleasure of working with several early-stage companies this year. These companies offer exciting technology, including emerging market ventilation, AI surgical planning, surgical navigation, interventional robotic tumor ablation, vascular solutions, dual array ultrasound on a finger probe, and knotless suturing for MIS procedures.
Fenske: What’s the most common challenge customers inquire about and how do you address it?
Joffroy-Black: For our early-stage clients, the biggest challenge is clinical validation of their technologies. The key is to continue to provide clinical evidence of success in how each technology addresses an unmet clinical need.
Fenske: If you could give one piece of advice to companies seeking a manufacturing partner before they make a decision, what would it be?
Joffroy-Black: Keep the “end in mind.” Early-stage companies need flexibility to build their platform and to also transfer their technology to strategic partners at the appropriate time.
Fenske: What are the forces driving medical device manufacturers to seek your technology/services over doing it in-house?
Joffroy-Black: Strategic partners are the key to our early-stage clients’ success. They are seeking innovation to bring “in-house” for manufacturing and, more importantly, to fit their sales channels for inorganic growth.
Fenske: In what ways is your company able to aid in getting a product (project) to market faster?
Joffroy-Black: MedWorld Advisors specializes in connecting mid-market and early-stage companies with strategic OEM partners for mutual “win-win” collaborations, including licensing, acquisition, and distribution. Our global team and our strategic contacts enable partnerships that benefit both partners to move forward more quickly.
MedWorld Advisors is located at Medica/Compamed in Hall 16, Booth/Stand A02.